Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | FKB238 |
| Trade Name | |
| Synonyms | HD204|BP102|SCT501 |
| Drug Descriptions |
FKB238 is a biosimilar to Avastin (bevacizumab), which is a VEGFA targeted antibody (J Clin Oncol 35, 2017 (suppl; abstr e14007)). |
| DrugClasses | VEGFA Antibody 5 |
| CAS Registry Number | NA |
| NCIT ID | NA |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| Carboplatin + FKB238 + Paclitaxel | Carboplatin FKB238 Paclitaxel | 0 | 1 |
| FKB238 | FKB238 | 0 | 0 |